Form D · Biotechnology
Atreca, Inc.
Redwood City, CA · CIK 0001532346
Offering snapshot reported Sep 19, 2018 · SEC filing
- Reported sold
- $125M Offering amount: $125M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 5, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 19, 2018 | Initial | $124,999,979 | No comparison | 43 | SEC filing |
| Dec 7, 2017 | Amendment | $35,000,003 | $0vs Aug 24, 2017 | 71 | SEC filing |
| Aug 24, 2017 | Initial | $35,000,003 | No comparison | 71 | SEC filing |
| Dec 4, 2015 | Initial | $57,261,706 | No comparison | 88 | SEC filing |
| Dec 4, 2015 | Initial | $0 | No comparison | 1 | SEC filing |
| Sep 12, 2013 | Initial | $700,000 | No comparison | 1 | SEC filing |
| Sep 26, 2012 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Sep 26, 2012 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Sep 26, 2012 | Initial | $40,000 | No comparison | 1 | SEC filing |
| Sep 26, 2012 | Initial | $350,000 | No comparison | 1 | SEC filing |
| Oct 18, 2011 | Initial | $160,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $4.5M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-321684
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cowen and Company, LLC | 7616 |
Source: Form D, filed Sep 19, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Atwood | Director |
| Franklin Berger | Director |
| Susan Berland | Executive |
| David Lacey | Director |
| John Orwin | Director, Executive |
| William Robinson | Director |
| Tito Serafini | Director, Executive |
| John Simpson | Director |
| Lawrence Steinman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
500 Saginaw Drive, First Floor
Redwood City, CA, 94063
Redwood City, CA, 94063